Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases by Cellarity | Jan 4, 2024 | Uncategorized
Cellarity Announces the Expansion of Its Partnership with Novo Nordisk to Discover and Develop a Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform by Rachel Black | Jan 4, 2024 | Uncategorized
Cellarity to Present at the 42nd Annual J.P. Morgan Healthcare Conference by Rachel Black | Jan 3, 2024 | Uncategorized
Cellarity Named a Top Place to Work for 2023 by The Boston Globe by Rachel Black | Dec 4, 2023 | Uncategorized
Cellarity Announces Partnership with Chan Zuckerberg Initiative to Advance New Machine Learning Algorithms for Single-Cell Analysis by Rachel Black | Oct 17, 2023 | Uncategorized
Recent Comments